Association de Formation Médicale Continue - Formation et Informations Médicales - ---------au service des professionnels de santé et de la santé ------------ depuis 1974

Calculs rénaux et risque de maladie cardiovasculaire (MCV).


Calculs rénaux et risque de maladie cardiovasculaire (MCV).

Résultats d'une étude prospective incluant 45.988 hommes de 40-75 ans :

ceux qui avaient eu une néphrolithiase avant leur inclusion ont eu un risque de MCV
significativement augmenté de 15 % :

IDM + 16 % ;
angor + 26 % ;
pontage + 23 %.

Il n'y a pas eu augmentation du risque d'AVC.

Ces résultats renforcent l'hypothèse d'un trouble vasculaire systémique à l'origine de la néphrolithiase .

Eisner & Coll., Abstract 1362, Réunion annuelle de l'American Urological Association, Anaheim, 21 mai 2007.



Brian H Eisner, MD, Matthew R Cooperberg, MD, Gary C Curhan, ScD, MD, Marshall L Stoller, MD. Massachusetts General Hospital, Harvard Medical School, Boston, MA; University of California, San Francisco, School of Medicine, San Francisco, CA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Introduction and Objective: The etiology of nephrolithiasis is incompletely characterized. We have hypothesized that the initial stone event may be vascular in origin, and therefore that patients with nephrolithiasis may manifest systemic vascular disease. We undertook a study to examine whether a history of nephrolithiasis is associated with subsequent development of cardiovascular disease. Methods: A prospective analysis of a large cohort, the Health Professionals Follow-up Study (N=45,988 men, age range at baseline 40-75 years) was performed. Multivariable regression models adjusted for age, body mass index, thiazide diuretic use, anti-hypertensive and cholesterol-lowering medications, tobacco use, history of gout or diabetes mellitus, fluid intake, and other dietary factors. Endpoints were coronary heart disease (CHD), defined as myocardial infarction, angina, or need for coronary artery bypass graft (CABG), and stroke, including ischemic or hemorrhagic cerebrovascular accidents. Results: 4747 (10.3%) patients reported a history of nephrolithiasis at baseline. After adjustment for potential confounders, the multivariate relative risk (RR) of CHD among men with a history of nephrolithiasis compared to those without nephrolithiasis was 1.15 (95% CI, 1.06-1.26; P=0.001). Relative risks for individual outcomes included a RR of 1.16 for myocardial infarction (95% CI, 1.02-1.33; P=0.03), 1.26 for angina (95% CI, 1.01-1.60; P=0.04), and 1.23 for CABG (95% CI, 1.07-1.40; P=0.003). There was no increased risk of stroke (RR = 1.0, 95% CI, 0.81-1.25; p=0.9). Conclusions: Nephrolithiasis is associated with a modest yet statistically significant increased risk of coronary heart disease. These results are consistent with findings in other recent studies suggesting that nephrolithiasis may reflect a systemic vascular disorder. These findings may contribute to our understanding of the etiology of stone formation, and may be important in counseling stone patients regarding future risk of CHD.

Partager cet article
Pour être informé des derniers articles, inscrivez vous :